SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-10-169317
Filing Date
2010-07-29
Accepted
2010-07-28 18:06:50
Documents
4
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 451602
2 CERTIFICATION OF PEO REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A) dex311.htm EX-31.1 9984
3 CERTIFICATION OF PFO REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A) dex312.htm EX-31.2 9986
4 SECTION 1350 CERTIFICATIONS dex321.htm EX-32.1 5046
  Complete submission text file 0001193125-10-169317.txt   478212
Mailing Address 201 INDUSTRIAL ROAD SAN CARLOS CA 94070
Business Address 201 INDUSTRIAL ROAD SAN CARLOS CA 94070 6506313100
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24006 | Film No.: 10975318
SIC: 2834 Pharmaceutical Preparations